Welcome to our dedicated page for Sobr Safe news (Ticker: SOBR), a resource for investors and traders seeking the latest updates and insights on Sobr Safe stock.
SOBR Safe, Inc. develops hardware and software for non-invasive alcohol detection and monitoring. The company’s touch-based transdermal technology is used in SOBRcheck and SOBRsure devices, with software that supports biometric identity verification, cloud-based alerts, reporting, and subscription revenue.
Recurring SOBR news covers operating results, commercialization of SOBRsure hardware and software, third-party technology validation, intellectual-property protection for SOBRcheck, and market positioning in behavioral health, family law, consumer, licensing, and integration channels. Company updates also include private placements, warrant and share issuances, governance matters, shareholder voting items, and Nasdaq-rule capital actions.
SOBRsafe (Nasdaq:SOBR) closed the previously announced cash exercise of certain outstanding warrants originally issued in December 2025 to purchase up to 2,360,648 shares of common stock at $1.30 per share, generating approximately $3.1 million in gross proceeds before fees and expenses.
In connection with the immediate exercise, SOBRsafe issued new unregistered Series E warrants to purchase up to 2,580,648 shares and Series F warrants to purchase up to 2,140,648 shares, each with a $1.30 exercise price and different expiry terms tied to the effective date of a future resale registration statement. According to SOBRsafe, net proceeds will be used for working capital and general corporate purposes, supporting its balance sheet and proposed merger.
SOBR Safe (Nasdaq:SOBR) entered into definitive agreements for the immediate cash exercise of certain outstanding warrants covering up to 2,360,648 shares, originally issued in December 2025, with the exercise price reduced from $1.30 to $1.05 per share. In connection with these exercises, SOBR Safe will issue new unregistered Series E and Series F warrants, each to purchase up to 2,360,648 shares at an exercise price of $1.30.
The Series E warrants will be exercisable immediately and expire five years after the effective date of a resale registration statement, while the Series F warrants will expire 24 months after that date. Aggregate gross proceeds are expected to be about $3.1 million before fees, with closing anticipated on or about July 16, 2026. According to SOBR Safe, net proceeds will support working capital, general corporate purposes, a proposed merger and efforts to regain Nasdaq listing compliance.
SOBRsafe (Nasdaq:SOBR) entered a definitive agreement to combine its alcohol monitoring business with Clean World Ventures (CWV), a zero-carbon green energy technology manufacturer. CWV would own approximately 98% of the combined public company, with close expected in Q3 2026, subject to approvals and customary conditions. The deal includes pre-close third-party financing committed to SOBRsafe of approximately $5.5 million, of which $2.0 million will be used by the SOBRsafe operating company at closing. The SOBRsafe and CWV businesses are planned to operate independently post-closing.
SOBRsafe (NASDAQ:SOBR) closed a private placement priced at-the-market under Nasdaq rules, raising approximately $2.0 million gross on December 29, 2025. The offering issued 1,290,324 shares (or pre-funded warrants) plus Series C and Series D warrants each to purchase up to 1,290,324 shares. Purchase price was $1.55 per share and the warrants have an $1.30 exercise price and are exercisable immediately. Series C warrants expire five years after the resale registration effective date; Series D expire 24 months after that date. H.C. Wainwright acted as placement agent; net proceeds will be used for working capital and general corporate purposes.
SOBRsafe (Nasdaq:SOBR) entered definitive agreements for a private placement expected to raise approximately $2.0 million gross through the sale of 1,290,324 common shares (or pre-funded warrants) at $1.55 per share and associated warrants. The company will also issue Series C and Series D warrants to purchase up to 1,290,324 shares each; warrants carry a $1.30 exercise price and are exercisable immediately.
H.C. Wainwright & Co. is the exclusive placement agent. Closing is expected on or about December 29, 2025. Proceeds are intended for working capital and general corporate purposes. Securities were sold to accredited investors under Section 4(a)(2)/Reg D and are subject to a resale registration obligation.
SOBRsafe (Nasdaq:SOBR) reported third quarter 2025 results for the period ended September 30, 2025. Revenue rose 136.1% YoY to $108.9k, driven by SOBRsure GEN 2 device and subscription sales; 277 GEN 2 devices were sold, up 55.6% QoQ. ARR from subscriptions reached $152.2k, a 60.5% quarterly increase. Gross profit was $37.9k with a 34.8% gross margin, down from 65.3% year‑over‑year due to strategic price reductions and higher replacement costs. Operating loss widened to $(2.2)m. Cash and equivalents were $4.7m at quarter‑end.
Marketing and channel expansion drove a 266% increase in website traffic and the company reported its strongest monthly sales in October.
SOBRsafe (NASDAQ:SOBR), a leader in next-generation alcohol monitoring and detection technology, has announced its participation in the upcoming 2025 Gateway Conference. The company's management team will deliver their presentation on September 3rd at 2:00 PM PT at the Four Seasons Hotel in San Francisco.
The presentation will be available via live webcast with replay options. Additionally, the company's management will be conducting one-on-one meetings throughout the conference. Interested parties can request invitations or schedule meetings by contacting conference@gateway-grp.com.
SOBRsafe (NASDAQ:SOBR) has reported its Q2 2025 financial results, demonstrating significant growth in key metrics. The company achieved a 92.3% year-over-year and 20.3% quarter-over-quarter increase in total revenue, reaching $104.2 thousand. Gross margin improved to 57.5%, while net loss decreased to $2.0 million.
The company's SOBRsure™ GEN 2 devices showed strong performance, with 178 units shipped in Q2, representing a 35.9% increase from Q1 2025. Annual recurring revenue from software subscriptions grew 109.6% year-over-year, contributing 55.2% of total revenue. The company also expanded its global presence with a new European Patent for SOBRcheck™ and launched an enhanced B2B e-commerce platform.
[ "Revenue growth of 92.3% year-over-year and 20.3% quarter-over-quarter", "Gross margin improved to 57.5%, up 380 basis points year-over-year", "Software subscription revenue increased 109.6% year-over-year", "SOBRsure GEN 2 shipments increased 35.9% quarter-over-quarter", "Secured European Patent for SOBRcheck device", "Strong cash position of $8.5 million as of June 30, 2025" ]SOBR Safe (NASDAQ:SOBR) has secured a significant European Patent (EP4171362) for its SOBRcheck™ device, strengthening its intellectual property portfolio in alcohol monitoring technology. The patent, granted by the European Patent Office on July 10, 2025, covers the company's non-invasive transdermal alcohol screening system.
The patented technology combines transdermal alcohol sensors with biometric identification, featuring skin contact verification and environmental compensation for accurate readings. The system can store, analyze, and wirelessly transmit data in real-time. SOBRsafe plans to commence pilot tests in Europe in the second half of 2025, marking a significant step in its international expansion strategy.
SOBRsafe (NASDAQ:SOBR) announced significant validation results for its SOBRsure™ GEN 2 alcohol monitoring device following comprehensive third-party testing by KEA Technologies. The testing confirmed the device's strong core sensing capabilities, including rapid ethanol response times of 30 seconds or less and excellent calibration linearity.
The evaluation covered critical performance areas such as calibration linearity, environmental impacts, sensitivity and drift, and trace alcohol differentiation. The device demonstrated consistent performance across its expected environmental operating range, particularly in low-level ethanol detection scenarios.
CEO David Gandini highlighted that these results position SOBRsafe for expanded market share both domestically and internationally. The company plans to further enhance the technology's capabilities, focusing on low-level detection improvements and advanced diagnostic features.